Zidovudine
Product Images NDC 21695-369

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zidovudine (NDC 21695-369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (1b34c6ec Ac27 455e 976e D22cf9d81950 01)

Structure (1b34c6ec Ac27 455e 976e D22cf9d81950 01)
Chemical structure diagram of Zidovudine, illustrating its molecular configuration with functional groups and ring structures clearly depicted.*
FDA Label Image

Zidovudine 300mg (1b34c6ec Ac27 455e 976e D22cf9d81950 02)

Zidovudine 300mg (1b34c6ec Ac27 455e 976e D22cf9d81950 02)
Zidovudine 300mg tablets label by Physician Partner. The package contains 18 tablets, each with 300mg of Zidovudine USP. The label states white, coated, round, film-coated tablets marked with '2' on one side and '11' on the other. Manufactured by Aurobindo Pharma Limited, Hyderabad, India, and packed by Physician Partner, Thousand Oaks, CA. Storage instructions specify controlled room temperature 15-30°C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.